ÂÜÀòÂÒÂ×

Michael Egholm is an accomplished executive with extensive experience in the biotechnology and life sciences sectors. Currently serving as CEO and President of Standard BioTools since April 2022, Michael has also held key positions such as Board Member at Abbratech Inc and IsoPlexis. Prior to these roles, significant contributions were made as Chief Technology Officer at Danaher Corporation and President of Biopharmaceuticals at Pall Corporation. Michael's early career included leadership roles at 454 Life Sciences, Molecular Staging, Applied Biosystems, and PerSeptive Biosystems. Academic qualifications include a Ph.D. and Master's degree in Chemistry from Københavns Universitet - University of Copenhagen.